Future Research Surrounding PSMA-PET Parameters and Response to 177Lu-PSMA-617 in mCRPC by admin_63069 | Sep 16, 2022 | Related Topics Phillip H. Kuo, MD, PhD, spoke about the future of theragnostic imaging in patients with metastatic castration-resistant prostate cancer.